
| USA Number of Patients Treated |
Elekta
Treatment Statistics - USA
Indications Treated to June 2004
93 units in clinical operation June 2004,
75 sites reporting
Indications Treated:
|
 |
 |
| Vascular
Diseases |
| AVM |
8,855 |
| Cavernous Angiomas |
36 |
| Aneurysm |
18 |
| Other Vascular |
349 |
| Total: |
9,258 |
| Benign
Tumors |
| Acoustic Neuromas |
3,982 |
| Meningioma |
10,190 |
| Pituitary |
2,159 |
| Pineal |
230 |
| Craniopharyngioma |
283 |
| Hemangioblastoma |
351 |
| Chordoma |
272 |
| Trigeminal Neuroma |
350 |
| Schwannoma |
7,570 |
| Other Benign Tumors |
350 |
| Total: |
23,423 |
| Malignant
Tumors |
| Metastasis |
26,540 |
| Glial Tumors |
7,431 |
| Chondrosarcoma |
90 |
| Glomus Tumor |
155 |
| Ocular Melanoma |
35 |
| NPH Carcinoma |
270 |
| Hemangiopericytoma |
182 |
| Other Malignant Tumors |
885 |
| Total: |
35,216 |
| Total Tumors: |
58,639 |
| Functional
Targets |
| Intractable Pain Targets |
240 |
| Trigeminal Nerve |
10,425 |
| Parkinsonian Targets |
357 |
| Psychoneurosis Targets |
28 |
| Epilepsy |
52 |
| Other Functional Targets |
395 |
| Total: |
11,504 |
| Total Indications:
|
79,463 |
| Cumulative
Indications Treated in the United States: |
| Malignant Tumors: |
43% |
| Benign Tumors: |
30% |
| Vascular Disorders: |
14% |
| Functional Disorders: |
13% |
| Vascular
Diseases Treated: |
| AVMs |
96% |
| Other Vascular |
4% |
| Total: |
9,258 |
| Benign
Tumors Treated: |
| Acoustic Neuromas |
30% |
| Meningioma |
44% |
| Pituitary |
14% |
| Other Benign Tumors |
12% |
| Total: |
23,423 |
| Malignant
Tumors Treated: |
| Metastasis |
75% |
| Glial Tumors |
21% |
| Other Malignant Tumors |
4% |
| Total: |
35,216 |
| Functional
Targets Treated: |
| Trigeminal Nerve |
90% |
| Parkinson's Targets |
3% |
| Intractable Pain Targets |
1% |
| Other Functional Targets |
6% |
| Total: |
11,504 |
| |
|
| Complete Adobe PDF Document |
|
|
 |
|
 |